Nextech Invest, Ltd.
Long book
$1.42B
Q1 2026
Positions
17
Top-10 weight
96%
concentration
Last quarter
+54.7%
SPY +14.8%
Turnover
17%
of book per quarter
Strategy in plain words
auto-generated from filingsNextech Invest, Ltd. is a concentrated fundamental stock-picker, specialised in healthcare (100% of the long book), running a $1.42B US long book across 17 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is modest: positions are typically held for years. Current anchor positions: REVOLUTION MEDICINES INC, TYRA BIOSCIENCES INC, TANGO THERAPEUTICS INC, ORIC PHARMACEUTICALS INC, ALUMIS INC.
Over the last 5 quarters its long book ran on average 30.2pp per quarter ahead of the S&P 500, beating the index in 5 of 5 quarters. We rate its filings highest-signal: new buys here are worth attention.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2025
+15.3%
Q2 2025
+27.3%
Q3 2025
+51.7%
Q4 2025
+34.3%
Q1 2026
+54.7%
Sector allocation
Healthcare 100%
Long book by quarter
What does Nextech Invest, own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| RVMD REVOLUTION MEDICINES INC | Healthcare | 7.6M | $739.2M | 52.0% | Held |
| TYRA TYRA BIOSCIENCES INC | Healthcare | 4.1M | $155.3M | 10.9% | Held |
| TNGX TANGO THERAPEUTICS INC | Healthcare | 7.3M | $152.0M | 10.7% | Held |
| ORIC ORIC PHARMACEUTICALS INC | Healthcare | 7.2M | $90.8M | 6.4% | Held |
| ALMS ALUMIS INC | Healthcare | 3.5M | $78.0M | 5.5% | +21.4% |
| RLAY RELAY THERAPEUTICS INC | Healthcare | 5.5M | $55.0M | 3.9% | +17.5% |
| ZYME ZYMEWORKS INC | Healthcare | 1.1M | $27.9M | 2.0% | Held |
| KYMR KYMERA THERAPEUTICS INC | Healthcare | 278.9K | $23.2M | 1.6% | Held |
| CTMX CYTOMX THERAPEUTICS INC | Healthcare | 4.4M | $20.9M | 1.5% | New |
| CNTX CONTEXT THERAPEUTICS INC | Healthcare | 7.4M | $19.4M | 1.4% | Held |
| CGEM CULLINAN THERAPEUTICS INC | Healthcare | 1.1M | $16.2M | 1.1% | Held |
| ENGN enGene Therapeutics Inc | Healthcare | 2.3M | $15.8M | 1.1% | +9.4% |
| CRVS CORVUS PHARMACEUTICALS INC | Healthcare | 450.0K | $6.6M | 0.5% | New |
| ARVN ARVINAS INC | Healthcare | 539.4K | $5.7M | 0.4% | Held |
| GLUE MONTE ROSA THERAPEUTICS INC | Healthcare | 304.2K | $5.0M | 0.4% | +9.0% |
| SPRY ARS PHARMACEUTICALS INC | Healthcare | 610.7K | $4.9M | 0.3% | -7.6% |